French Trial Tragedy: The Investigations Begin
This article was originally published in Scrip
Executive Summary
A French Senate committee has intervened in the debate over the Phase I study of a new drug that caused the death of one volunteer and left a number of others hospitalized, saying that it plans to meet with the government inspectors who visited the site in Rennes to discuss their findings, with a view to looking afresh at the legislation governing clinical trials.